COTA

Vice President, Life Science

New York, New York, United States

COTA Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, Biotechnology, Medical Diagnostics, Real-World EvidenceIndustries

Requirements

The Vice President of Life Sciences should possess a strong understanding of the Life Science and real world evidence industries, demonstrating strategic and consultative hunting experience in a fast-paced, customer-focused environment. They should have experience working with emerging and mid-sized biotechnology companies as well as medical diagnostic companies, and be capable of building and managing a sales funnel and pipeline to accurately forecast sales achievement.

Responsibilities

As the Vice President of Sales, the individual will be responsible for managing all aspects of the sales process, including hunting new clients, lead generation, and sales closure. They will produce market and specific account plans, execute those plans to achieve annual sales targets, generate revenue through breaking into new Life Science companies, build relationships with key contacts, identify and break into new accounts, and bring forth innovative ideas to develop and close opportunities.

Skills

Strategic Sales
Client Acquisition
Account Management
Market Planning
Pipeline Forecasting
Life Science Industry Knowledge
Real-World Evidence
Biotechnology
Medical Diagnostics
Customer Relationship Building
Consultative Selling

COTA

Data analytics for cancer care improvement

About COTA

COTA Healthcare focuses on improving cancer care through technology and data analytics. They analyze real-world data related to oncology, which helps healthcare providers, researchers, and pharmaceutical companies make better decisions regarding patient treatment. COTA's solutions clarify fragmented data, providing actionable insights that aim to reduce variations in care quality and enhance patient outcomes. Unlike many competitors, COTA specifically targets the oncology sector and partners with various stakeholders in the cancer treatment ecosystem to deliver tailored insights. The company's goal is to ensure that every cancer patient receives the most appropriate and effective care possible.

Key Metrics

New York City, New YorkHeadquarters
2011Year Founded
$73MTotal Funding
CONVERTIBLECompany Stage
Data & Analytics, HealthcareIndustries
201-500Employees

Risks

Over-reliance on AI could lead to inaccuracies if data isn't properly validated.
Multiple partnerships may lead to conflicts of interest or data privacy concerns.
Intensifying competition in oncology data analytics threatens COTA's market position.

Differentiation

COTA uses proprietary technology to organize complex oncology data for actionable insights.
Partnerships with companies like Guardant Health enhance COTA's precision oncology capabilities.
COTA's AI-powered curation engine, CAILIN™, transforms fragmented data into valuable insights.

Upsides

Growing AI adoption in healthcare aligns with COTA's precision oncology focus.
COTA's collaboration with the FDA strengthens its role in regulatory decision-making.
Partnerships with Caris Life Sciences expand COTA's multi-modal data offerings.

Land your dream remote job 3x faster with AI